HEATHER SARKIS: Open Payments
NPI 1023118122 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 42 payments from 12 companies in 2025. Trend: 2023 $641 · 2024 $555 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $144 |
| ABBVIE INC. | 8 | $139 |
| Abbott Laboratories | 2 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Lilly USA, LLC | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 5 | $48 |
| Boston Scientific Corporation | 1 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| bioMerieux Inc | 1 | $18 |
Products named: NURTEC ODT, UBRELVY, AMPLATZER AMULET, VOQUEZNA, WATCHMAN FLX, QULIPTA, MOUNJARO, AIRSUPRA.
Industry payments across ID — which companies pay providers there.
